first_imgSolar Energy Possibilities Begin to Take Root in Puerto Rico FacebookTwitterLinkedInEmailPrint分享InsideClimate News:On average, power plants on the island are about 44 years old, and most are run by the main utility company, Puerto Rico Electric Power Authority (PREPA), which filed for bankruptcy this year and is $9 billion in debt.Because Puerto Rico has to start from scratch, it has an opportunity to solve many of its long-term energy problems and shift to a cleaner energy source that is dropping in price, said Cathy Kunkel, of the Institute for Energy Economics and Financial Analysis.“Microgrids are pretty key to build in sustainable way that’s more resilient going forward,” she said.The cost of renewables is comparable to the prices customers already paid for electricity, and a new, decentralized grid would be more conducive to integrating distributed energy, Kunkel said. That could help raise the island’s renewable energy portfolio, which is currently only at 2 percent, and make it more resilient to future storms.The interest from private companies is already there. Solar companies like Sonnen and Sunrun are partnering with local nonprofits to provide battery and solar supplies. Tesla has been among the most ambitious with its efforts: in late September, Bloomberg reported the company was shipping hundreds of Powerwalls―its home batteries that can store energy from rooftop solar―to the island. Musk has been in talks with Gov. Ricardo Rossello to scale up the effort by sending Powerpacks―giant battery packages equal to 16 Powerwall batteries―to bring hospitals and city centers back online.That battery technology “could be used effectively to restore electricity to rural and isolated communities first, where they could provide electricity well ahead of when grid rebuilding efforts are likely to reach those communities,” said Clark Miller, associate director of the School for the Future of Innovation in Society at Arizona State University, which partners with the University of Puerto Rico’s National Institute of Energy and Sustainability.The new microgrids could work in tandem with the fossil fuel-powered centralized electricity grid, particularly in future storms like Maria, energy experts say.“These can provide individual pockets of power that would be hugely supportive to emergency relief and communications, to light and power tools for rebuilding, for the cleaning and distribution of water next time,” said Roy Torbert, principal on the Islands Energy Program at the Rocky Mountain Institute.More: Puerto Rico’s Solar Future Takes Shape at Children’s Hospital, with Tesla Batterieslast_img read more

first_imgDube and Lenz will also work with Keck School of Medicine assistant professor of translational genomics Bodour Salhia during the trial. Salhia will collect blood samples from patients to look for molecular biomarkers to identify people who are at high risk for developing severe symptoms. Keck Medicine of USC will launch a clinical trial to study the effects of an anti-inflammatory drug on treating patients with the coronavirus, according to a Wednesday press release from Keck Medicine. The medication, baricitinib, has been approved by the Food and Drug Administration to treat rheumatoid arthritis.  The double-blind study, which will run for three months, is expected to survey the effects of baricitinib on 144 random patients with moderate to severe coronavirus infections from Los Angeles County + USC Medical Center, Keck Hospital of USC and USC Verdugo Hills Hospital. Half of the patients will receive the drug, while the other half will receive a placebo.  Participants will include patients who exhibit moderate to severe symptoms of the coronavirus infection but who have not reached a critical stage requiring intubation. Patients with higher risk factors are also eligible to participate. Inflammation resulting from the virus may be the underlying cause behind severe respiratory complications that require hospitalization and intubation, said Dr. Michael Dube, a Keck Medicine infectious disease specialist and the Keck School of Medicine interim chief of infectious diseases, in the press release. Dube is conducting the trial alongside Heinz-Josef Lenz, associate director of clinical research at the USC Norris Comprehensive Cancer Center, who serves as the main investigator in the study. Dube said the researchers hope to start enrolling patients in the study starting Thursday. For some patients, the virus can trigger a cytokine storm, an immune response with a large number of small infection-fighting proteins which in greater quantities can damage tissue and lead to organ failure, Dube said. Research has indicated that baricitinib lowers the levels of certain cytokines.center_img “Our premise is that by using baricitinib to reduce the inflammation, we may be able to slow down the progress of the disease, stop the need for a ventilator and save lives,” Dube said in the press release. In addition to piloting the study, Keck Medicine resumed a limited number of medically necessary and time-sensitive procedures and surgeries at select locations, including Verdugo Hills Hospital and Keck Medical Center, Monday. Nonemergent but medically necessary elective operations, along with gynecological, orthopedic and general surgeries, are some of the services that have resumed and will be expanded May 11.   “The primary problem that is occurring in people who develop critical illness … is excessive inflammation in the body, and that affects the lungs and other organs,” Dube said. “[Baricitinib] appears to be able to affect some of the key inflammation pathways that are leading to critical illness in COVID-19.” In a Monday press release, Keck Medicine said it is resuming services in accordance with public health guidelines. The medical center said it is maintaining the health and safety of its employees by providing personal protective equipment, screening for fevers upon entrance into its facilities, testing patients for the coronavirus at least 72 hours in advance of their procedures and continuing its telemedicine services for nonemergent services. According to Dube, patients with moderate disease have at least one risk factor — age greater than 60, diabetes, morbid obesity or high blood pressure — in addition to the coronavirus and signs of pneumonia. Patients with severe disease have low oxygen levels in their blood.  last_img read more

first_imgView comments Wang, though, is optimistic about China’s chances.“It is my second World Cup. I was given a substitute role at Canada 2015 as a young player but I didn’t score. So my initial goal is to break my Women’s World Cup duck this time around. I want to score as many goals as possible and help my team to a good result.”Sports Related Videospowered by AdSparcRead Next MOST READ Japeth Aguilar embraces role, gets rewarded with Finals MVP plum Lights inside SMX hall flicker as Duterte rants vs Ayala, Pangilinan anew Jose Mourinho leaves Man United after more than 2 years Gretchen Barretto’s daughter Dominique graduates magna cum laude from California college Nadine Lustre’s phone stolen in Brazil Trending Articles PLAY LIST 00:50Trending Articles00:50Trending Articles00:50Trending Articles02:14Carpio hits red carpet treatment for China Coast Guard02:56NCRPO pledges to donate P3.5 million to victims of Taal eruption00:56Heavy rain brings some relief in Australia02:37Calm moments allow Taal folks some respite03:23Negosyo sa Tagaytay City, bagsak sa pag-aalboroto ng Bulkang Taal01:13Christian Standhardinger wins PBA Best Player award LATEST STORIES No.13 lucky for Orlando Bloom Ginebra beats Meralco again to capture PBA Governors’ Cup title PSG trails leader Lyon by two points at the top of the standings, with the league resuming on Jan 12.As well as PSG’s quest for glory on the domestic and European fronts, it promises to be a big year for Wang, who hopes her skills can help steer China to a deep run at next summer’s World Cup finals in France.“I think my experiences in France will be an advantage to me to compete in the Women’s World Cup here,” the 23-year-old said during a recent interview with“Paris is the home of PSG. We face not only teams from the French league, but also from other countries during the Women’s Champions League and these teams represent the best of Europe.”China faces a tough task at the World Cup, however, after drawing European powerhouses Germany (a two-time world champion and ranked No 2) and Spain (No 12), as well as the 48th-ranked South Africa.ADVERTISEMENT Lights inside SMX hall flicker as Duterte rants vs Ayala, Pangilinan anew After winning title, time for LA Tenorio to give back to Batangas folk ‘Mia’: Rom-com with a cause a career-boosting showcase for Coleen Garcia Marie-Antoinette Katoto finished with a hat-trick, Ashley Lawrence bagged a brace while Kadidiatou Diani was also on target for the host in its last game before the winter break.Playmaker Wang, dubbed ‘Lady Messi’ by fans, was delighted to end 2018 on a high.FEATURED STORIESSPORTSGinebra beats Meralco again to capture PBA Governors’ Cup titleSPORTSJapeth Aguilar wins 1st PBA Finals MVP award for GinebraSPORTSGolden State Warriors sign Lee to multiyear contract, bring back Chriss“It feels good to score in the last match of the year,” Wang, who signed for PSG in August, told Xinhua after the game.“I still feel that the team has experienced ups and downs. Some-times we play quite well and sometimes pretty bad. We are still a young group, so it’s quite normal.” China’s Wang Shuang congratulates Paris Saint-Germain teammate Kadidiatou Diani on her goal during PSG’s 7-1 victory over Metz in a Division 1 Feminine match in Paris on Sunday. DAVE WINTER/ICON SPORT/GETTY IMAGESChinese star Wang Shuang continued to show her world-class pedigree with a goal in a dominant French league victory for Paris Saint-Germain on Sunday.The recently crowned Asian women’s player of the year hit the net in the 58th minute with a leftfoot strike as PSG routed Metz 7-1 at Stade Jean Bouin to extend its unbeaten record to 14 matches-a run that includes 12 wins.ADVERTISEMENT Don’t miss out on the latest news and information. last_img read more